We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle (397093)

ARTG ID 397093

ARTG Name

TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle

Product name

TAFINLAR dabrafenib (as mesilate) 10 mg dispersible tablet bottle

ARTG Date

6 December 2023

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

dabrafenib mesilate

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

TAFINLAR dabrafenib (as mesilate) 10 mg dispersible tablet bottle , Novartis Pharmaceuticals Australia Pty Ltd , CON-1185

29 November 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 29 November 2023 until 29 November 2025.
TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle (2023-24)

2023-24

Annual charge exemption

Exempt from annual charge in 2023-24 due to Novartis Pharmaceuticals Australia Pty Ltd declaring $0 turnover in that period.